Background: No consensus exists in the clinical transcranial magnetic stimulation (TMS) field as to the best method for targeting the left dorsolateral prefrontal cortex (DLPFC) for depression treatment. Two common targeting methods are the Beam F3 method and the 5.5 cm rule.
Dear editor:
Repetitive transcranial magnetic stimulation (TMS) is an effective treatment for major depressive disorder when targeted at the left prefrontal cortex (1) . The optimal cortical target within the left prefrontal cortex is controversial and, to date, lacks standardization (1) (2) (3) . Two targeting methods have become mainstream options for clinicians -the 5.5 cm rule and the Beam F3 method (4, 5) . Beam F3 targeting accounts for head size and shape, whereas most of the early clinical trials were conducted with the 5.5 cm rule (4) (5) (6) . Neither targeting method requires neuroimaging for target localization, but both potentially sacrifice precision and reproducibility due to some degree of error inherent in using scalp targeting methods (7, 8) .
Minimizing spurious variability in identifying the treatment target is important for consistency. To our knowledge, this study is the first to compare the reproducibility of identifying the Beam F3 and the 5.5 cm target, evaluating both differences between technicians and the consistency of individual technicians with repeated measures. We establish data-driven average brain and scalp coordinates for these targets based on our results and relate these to other coordinates proposed in the literature.
Ten healthy subjects, ages 20 to 44 (average age 31.0, six male and four female), participated in the study. Subjects obtained T1-weighted 7T MRI brain scans within 30 days of participation. Images were loaded into Brainsight (Rogue Research, Montreal, Quebec) for neuronavigation-based measurements.
Three trained TMS technicians performed repeated scalp measurements on each subject at three time points over the course of 1 month, with at least 24 hours separating measurement sessions (n=162 total measurements, 81 at each scalp target). The Beam F3 and 5.5 cm rule target were measured using standard measurement procedures (1, 4) . The Beam F3 method incorporated the adjustments recommended by Mir-Moghtadaei et al (2) . Points were then registered on each subject's MRI using Brainsight.
Distances between the targets as identified by the two methods were measured both on the scalp directly and using Brainsight tools. The anatomical images and associated target coordinates were warped into a common anatomical space (MNI152) and analyzed with Freesurfer. We first evaluated reliability between the Beam F3 method and the 5.5 cm rule. We separately evaluated inter-rater reliability relative to a group-averaged target coordinate and intra-rater reliability relative to a technician-specific average target coordinate. Generalized linear mixed models were used to test for differences in distance between targeting methods with random effects for subject and technician. We also calculated the average MNI152 coordinates from each method, with cortical targets represented by the coordinate on the pial surface closest to the scalp, identified using Freesurfer. Additional details of the targeting methods, imaging processing, and statistical analysis are available in Supplemental Appendix A. Figure 1A shows the spatial distribution of all Beam F3 (red) and 5.5 cm (green) measurements as well as group mean centroids (black) displayed on an MNI152 composite scalp; Beam F3 targets were on average more anterolateral than 5.5 cm rule targets. The gross mean distance between an F3 target and An important contribution from this study is the generation of standardized average Beam F3 and 5.5 cm rule coordinates in MNI152 space, both on the cortical and scalp surfaces. These coordinates can serve as reference points for future research.
Taken together, our findings suggest that the Beam F3 method allows for improved inter-and intra-rater reliability and precision compared to the 5.5 cm rule and identifies a target more than 2 centimeters anterolateral to the 5.5 cm target. While the Beam F3 method has a higher level of precision and reproducibility compared to the 5.5 cm rule, evidence tying the Beam F3 method to greater treatment efficacy is limited. Comparative efficacy trials of the different targeting methods are needed to guide clinical recommendations. ^Reference details are listed in Supplemental Tables 1 & 2. 
